Favipiravir
Generic / Active Ingredient
What is Favipiravir used for?
Influenza
24 Favipiravir brands in Bangladesh
Compare prices across every brand of Favipiravir and pick the most affordable option.
| Brand | Strength | Form | Manufacturer | Price |
|---|---|---|---|---|
| Akarvia | 200 mg | Tablet | Incepta Pharmaceuticals Ltd. | ৳ 400.00 |
| Biofavi | 200 mg | Tablet | Biopharma Laboratories Ltd. | ৳ 200.00 |
| Fapiravir | 200 mg | Tablet | Healthcare Pharmaceuticals Ltd. | ৳ 200.00 |
| Fapravir | 200 mg | Tablet | Renata Limited | ৳ 200.00 |
| Favigan | 200 mg | Tablet | Ziska Pharmaceuticals Ltd. | ৳ 400.00 |
| Favilar | 200 mg | Tablet | Popular Pharmaceuticals Ltd. | ৳ 200.00 |
| Favinil | 200 mg | Tablet | Square Pharmaceuticals Ltd. | ৳ 200.00 |
| Favipir | 200 mg | Tablet | Eskayef Pharmaceuticals Ltd. | ৳ 200.00 |
| Favipira | 200 mg | Tablet | Beacon Pharmaceuticals Ltd. | ৳ 200.00 |
| Favira | 200 mg | Tablet | Drug International Ltd. | ৳ 200.00 |
| Faviravir | 200 mg | Tablet | ACI Limited | ৳ 200.00 |
| Favirest | 200 mg | Tablet | Everest Pharmaceuticals Ltd. | ৳ 200.00 |
| Favitab | 200 mg | Tablet | Ibn Sina Pharmaceuticals Ltd. | ৳ 200.00 |
| Favivir | 200 mg | Tablet | Opsonin Pharma Ltd. | ৳ 200.00 |
| Fluvigan | 200 mg | Tablet | NIPRO JMI Pharma Ltd. | ৳ 200.00 |
| Fravir | 200 mg | Tablet | Orion Pharma Ltd. | ৳ 200.00 |
| Ivrenas | 200 mg | Tablet | Genvio Pharma Ltd. | ৳ 200.00 |
| Piravir | 200 mg | Tablet | ACME Laboratories Ltd. | ৳ 200.00 |
| Piravix | 200 mg | Tablet | Radiant Pharmaceuticals Ltd. | ৳ 200.00 |
| Rotagan | 200 mg | Tablet | Concord Pharmaceuticals Ltd. | ৳ 200.00 |
| Toyavir | 200 mg | Tablet | General Pharmaceuticals Ltd. | ৳ 200.00 |
| Unifav | 200 mg | Tablet | UniMed UniHealth | ৳ 200.00 |
| Verigan | 200 mg | Tablet | Veritas Pharmaceuticals Ltd. | ৳ 200.00 |
| Viraflu | 200 mg | Tablet | Beximco Pharmaceuticals Ltd. | ৳ 200.00 |
Indication DetailsView
Treatment of novel or re-emerging pandemic influenza virus infections (limited to cases in which other influenza antiviral drugs are ineffective or not sufficiently effective).
Therapeutic ClassView
Anti-viral drugs
PharmacologyView
Favipiravir is a new antiviral drug against influenza. It is metabolized into favipiravir ribosyl triphosphate (favipiravir RTP) by an intracellular enzyme, and favipiravir RTP selectively inhibits RNA polymerase (RNA-dependent RNA polymerase) of the influenza virus, preventing replication of the influenza virus. It is a drug with a mechanism of action different from that of the existing influenza antiviral drugs and effective against all types and sub-types of human influenza A, B, and C viruses in vitro, showing a wide range of anti-viral activity against various influenza virus strains including avian and swine viruses.
DosageView
The usual adult dosage is 1600 mg of Favipiravir administered orally twice daily on Day 1, followed by 600 mg orally twice daily from Day 2 to Day 5 or as directed by physicians. The total treatment duration should be 5 days.
Side EffectsView
Most common side effects are Diarrhea and increase of blood uric acid levels.
ContraindicationsView
Favipiravir is contraindicated for pregnant women and women who may possibly be pregnant.
PrecautionsView
Favipiravir should not be given in pregnant women, requirement of the confirmation of non-pregnancy in women of childbearing potential before use, thorough contraception measures from the start of the treatment to 7 days after the end of the treatment. Caution should be taken for Hepatic and renal impaired patient or use Favipiravir as per the direction of registered Physician
InteractionsView
In animal studies, decreased RBC production,and increases in liver function parameters such as AST, ALP, ALT and total bilirubin, and increased vacuolization in hepatocytes. Toxicity information regarding Favipiravir in humans is not readily available.
Pregnancy & LactationView
Favipiravir may cause delayed development or death of embryos during the early stage of pregnancy. Should not be given during pregnancy.
Pediatric UsageView
This drug is only approved as an experimental drug and still a lot of studies is needed about it’s efficacy and also toxic reactions and use in children.
Overdose EffectsView
In animal studies, decreased RBC production,and increases in liver function parameters such as AST, ALP, ALT and total bilirubin, and increased vacuolization in hepatocytes. Toxicity information regarding Favipiravir in humans is not readily available.
Storage ConditionsView
Keep below 30°C temperature, protected from light & moisture. Keep out of the reach of children.